Francisco Lindor’s 2027 Rebound Case: Power, Health and a Path Back

| 5 min read

Francisco Lindor’s 2026 numbers look worse than his underlying contact suggests. A fractured hamate, a two month absence with a strained calf and poor results on balls in play all weighed on the Mets shortstop. With his power and hard contact intact, a healthier 2027 could bring a meaningful rebound, though his defense may be entering a new phase.

Injuries shaped a disrupted season

New York finished 74-88 after entering the year with postseason hopes, and Lindor was among the veterans who fell short. He played 105 games, his fewest in a non-COVID season since 2015, and hit .225/.309/.423 across 469 plate appearances. His 21 home runs translated to a 105 wRC+, while his .309 on-base percentage was a career low and nine points below league average.

The season began with recovery from February surgery to repair a fractured hamate. Lindor made the Opening Day roster, but through April 22 he hit .226/.314/.355, good for a 90 wRC+. After returning from the calf injury on June 24, he produced a 109 wRC+ for the rest of the season. July was strong at 139; August and September were roughly average, at 99 and 100.

That uneven timeline matters. Lindor’s full-season line blends a difficult opening stretch, two months away and a steadier finish. It doesn’t erase the decline, but it offers a clearer explanation than a simple age-driven slump.

Contact quality supports an offensive rebound

The power indicators held up. Lindor’s .199 isolated slugging percentage matched his 2025 figure, while his average exit velocity reached a career-high 91.6 mph and his hard-hit rate climbed to a career-best 49.5%. Statcast placed those marks in the 88th and 91st percentiles, respectively.

His .242 batting average on balls in play was far below both the league average and his .289 career mark. That gap points to room for positive regression in 2027. Lindor chased pitches slightly more often than usual, but his 29.4% chase rate remained close to his career norms. He also struck out more than 20% of the time for the first time, though his 20.3% rate was still better than average.

There’s a specific area to watch: fastballs. Lindor went from +16 in run value against four-seamers in 2025 to -3 this year, and his slugging percentage against the pitch came in 53 points below expected. Yet he hit the ball hard against four-seamers more often than before, with that rate rising from 52.5% to 56.5%. His bat speed also increased, from 70.9 mph to 72.9 mph. If that strength carries over, he has a credible route back to punishing fastballs.

The longer record reinforces the case. From 2022 through 2025, Lindor posted a wRC+ between 120 and 136 each season and averaged 6.4 fWAR. Even in an injury affected year, he was worth 2.2 fWAR, production consistent with a solid everyday player.

Shortstop defense is the bigger question

Lindor’s glove declined alongside his health. In just under 900 innings at shortstop, he recorded -4 Defensive Runs Saved and zero Outs Above Average, both career lows. Statcast rated him -3 OAA when charging ground balls and -3 against left-handed hitters. Fielding Run Value put him around average after years of elite defensive evaluations.

The calf injury may have affected his movement, and a player entering his mid-30s is unlikely to regain every step. A healthier season could still bring some improvement, perhaps enough to make him an average or slightly above average shortstop. His range to either side remained just above average, according to Statcast, and he has succeeded at short despite never having a standout arm.

A move to second base remains a possibility, though it may not happen next season. As MLBTR’s Darragh McDonald wrote in the Mets’ offseason outlook, the club could eventually shift Lindor to the keystone. The organization also has a potential option in Jefferson Rojas, a consensus Top 100 prospect at Triple-A Syracuse. Rojas could get a shortstop trial while Lindor moves to second, or take reps at second or third while Lindor stays put.

Rojas mostly played third this year and has experience across the infield except at first base. That position is crowded if Bo Bichette stays with the Mets; most MLBTR readers expected Bichette not to opt out of his deal in a recent poll. The Mets have several ways to manage the alignment, but Lindor’s defense will help determine when they need to use them.

A rebound could steady a broader lineup

My read is that Lindor’s bat has a stronger rebound case than his glove. The contact quality, stable power and career history all point toward better results, while his defensive ceiling may settle below its former level. The Mets will also be looking for improvement from Bichette and Brett Baty, both of whom finished 4-8% below average after hitting above average last year. Juan Soto and Carson Benge remain lineup anchors, while Marcus Semien will need to answer a career-worst 74 wRC+ and poor defense.

For Lindor, a healthy season and better fortune on balls in play could restore his offense as a reliable strength. The key uncertainty is whether his legs allow him to remain an effective shortstop. New York’s 2027 outlook may depend on getting one answer from his bat and a workable one from his defense.

Photo courtesy of Raymond Carlin III, Imagn Images

Source: AJ Eustace · www.mlbtraderumors.com